Malignant Solitary Fibrous Tumors of the Pleura: Retrospective Review of a Multicenter Series Filippo Lococo, MD, Alfredo Cesario, MD, Giuseppe Cardillo,

Slides:

Advertisements

Similar presentations

A Clinical Prognostic Index for Patients Treated with Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21 Marie Florescu,

Advertisements

Noriyasu Usami, MD, Shingo Iwano, MD, Kohei Yokoi, MD

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib Nobukazu Agatsuma, MD Journal of.

Neoadjuvant Chemotherapy for Stage III and IVA Thymomas: A Single-Institution Experience with a Long Follow-up Marco Lucchi, MD, Franca Melfi, MD, Paolo.

Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib Nobukazu Agatsuma, MD Journal of.

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer Sai-Hong Ignatius Ou, MD, PhD, Jason.

Primary malignant melanoma of the bronchus intermedius

Surgical Treatment in Patient with Non–Small-Cell Lung Cancer with Fissure Involvement: Anatomical versus Nonanatomical Resection Giovanni Leuzzi, MD,

Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program Giulia Veronesi, MD, Massimo Bellomi, MD,

Long-Term Results after Treatment for Recurrent Thymoma: A Multicenter Analysis Alberto Sandri, Giacomo Cusumano, Filippo Lococo, MD, Marco Alifano, Pierluigi.

Mark F. Berry, MD, Thomas A. Sporn, MD, Joseph O. Moore, MD, Thomas A

Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901 Stephen L. Graziano,

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD

A Clinical Prognostic Index for Patients Treated with Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21 Marie Florescu,

Is Sleeve Lobectomy Comparable in Terms of Short- and Long-Term Results With Pneumonectomy After Induction Therapy? A Multicenter Analysis Giacomo Cusumano,

Multimodality Treatment of Stage III Non-small Cell Lung Cancer: Analysis of a Phase II Trial Using Preoperative Cisplatin and Gemcitabine with Concurrent.

Electronic Updates for JTO Readers

IA05.01 Lung Cancer Cases Journal of Thoracic Oncology

Surgery for oligometastatic non–small cell lung cancer: Long-term results from a single center experience Maria Teresa Congedo, MD, Alfredo Cesario,

Surgical Treatment for Octogenarians with Lung Cancer: Results from a Population- Based Series of 124 Patients Hes A.P. Brokx, MD, Otto Visser, MD, PhD,

Multimodality treatment of unresectable stage III non–small cell lung cancer: Interim analysis of a phase II trial with preoperative gemcitabine and concurrent.

An Unusual Presentation of Malignant Pleural Mesothelioma

Pathologic Findings and Long-Term Results After Surgical Treatment for Pulmonary Sarcomatoid Tumors: A Multicenter Analysis Filippo Lococo, MD, Cristian.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Frank Detterbeck, MD Journal of Thoracic Oncology

Surgical Treatment of a Giant Symptomatic Cardiac Lipoma

Pulmonary Resection for Metastatic Gastric Cancer

Localized (solitary) fibrous tumors of the pleura: an analysis of 55 patients Giuseppe Cardillo, MD, Francesco Facciolo, MD, Andrea O Cavazzana, MD, Girolamo.

Multiple Pulmonary Chondroid Hamartoma

Giant Alveolar Adenoma Causing Severe Dyspnoea

Jeffrey Bradley, MD, Issam El Naqa, PhD Journal of Thoracic Oncology

A Single Institution-Based Retrospective Study of Surgically Treated Bronchioloalveolar Adenocarcinoma of the Lung: Clinicopathologic Analysis, Molecular.

Karen M. Harrison–Phipps, MD, Francis C. Nichols, MD, Cathy D

Association between Congenital Lung Malformations and Lung Tumors in Children and Adults: A Systematic Review Arianna Casagrande, MD, Federica Pederiva,

A 10-Year Single-Center Experience on 708 Lung Metastasectomies: The Evidence of the “International Registry of Lung Metastases” Monica Casiraghi, MD,

Elizabeth B. Gottlin, PhD, Rex C. Bentley, MD, Michael J

Jeffrey T. Yorio, MD, Yang Xie, PhD, Jingsheng Yan, PhD, David E

Primary Malignant Pericardial Mesothelioma Mimicking Pericardial Metastasis from Adenocarcinoma Masafumi Horie, MD, Satoshi Noguchi, MD, Wakae Tanaka,

Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q

Synchronous Primary Lung Cancer, Breast Cancer Recurrence, and Mediastinal Silicon- Induced Lymphadenitis Francesco Petrella, MD, Gian Carlo Pruneri,

Solitary Fibrous Tumors of the Pleura: A Poorly Defined Malignancy Profile Guillaume Boddaert, MD, Patrice Guiraudet, MD, Bertrand Grand, MD, Nicolas.

Small-bore wire-guided chest drains: Safety, tolerability, and effectiveness in pneumothorax, malignant effusions, and pleural empyema Stefano Cafarotti,

Video-Assisted Thoracoscopic Surgery (VATS) for Patients with Solitary Fibrous Tumors of the Pleura Jun Liu, MD, Chengjie Cai, MD, Daoyuan Wang, MD,

Outcomes of Mediastinoscopy and Surgery with or without Neoadjuvant Therapy in Patients with Non-small Cell Lung Cancer Who are N2 Negative on Positron.

Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response

Elizabeth Cathcart-Rake, MD, Ariel Lopez-Chavez, MD, MS

Bronchial Oncocytoma With High 18F-Fluorodeoxyglucose Uptake Revealed by Nephrotic Syndrome Giovanni Leuzzi, MD, Alfredo Cesario, MD, Marco Chiappetta,

Prognostic Impact of Node Involvement Pattern in Pulmonary pN1 Squamous Cell Carcinoma Patients Masayuki Nakao, MD, Junji Yoshida, MD, PhD, Genichiro.

Pulmonary inverted schneiderian papilloma

ALK Translocation in Non-small Cell Lung Cancer with Adenocarcinoma and Squamous Cell Carcinoma Markers Samuel J. Klempner, MD, David W. Cohen, MD, Daniel.

Significance of the Presence of Microscopic Vascular Invasion After Complete Resection of Stage I–II pT1-T2N0 Non-small Cell Lung Cancer and Its Relation.

“Salvage” Surgery for Primary Mediastinal Malignancies: Is it Worthwhile? Francesco Petrella, MD, Francesco Leo, MD, PhD, Giulia Veronesi, MD, Piergiorgio.

Noriyasu Usami, MD, Shingo Iwano, MD, Kohei Yokoi, MD

The Prognostic Impact of Cigarette Smoking on Patients with Non-small Cell Lung Cancer Ryo Maeda, MD, Junji Yoshida, MD, PhD, Genichiro Ishii, MD, PhD,

It’s All in the “Swerve of the Curve”

Adjuvant Surgery after Carboplatin and VP16 in Resectable Small Cell Lung Cancer Giulia Veronesi, MD, Paolo Scanagatta, MD, Francesco Leo, MD, Tommaso.

Maintenance Therapy and Advanced Non–Small-Cell Lung Cancer: A Skeptic's View Martin J. Edelman, MD, Thierry Le Chevalier, MD, Jean-Charles Soria, MD,

International Thymic Malignancies Interest Group: A Way Forward

Linda L. Garland, MD, Kari Chansky, MS, Antoinette J

Features and Prognostic Factors of Large Node-Negative Non–Small-Cell Lung Cancers Shifted to Stage II Francesca Toffalorio, MD, PhD, Davide Radice,

Primary choriocarcinoma of the lung

Wedge Resection for Non-small Cell Lung Cancer in Patients with Pulmonary Insufficiency: Prospective Ten-Year Survival John P. Griffin, MD, Charles E.

Solitary fibrous tumor of the pleura mimicking neurogenic tumor

APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28

Jamie E. Chaft, MD, Camelia S. Sima, MD, MS, Michelle S

A B3 Type-Thymoma in a 7-Year-Old Child with Myasthenia Gravis

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Induction Therapy Followed by Surgery for T3-T4/N0 Non-Small Cell Lung Cancer: Long-Term Results Filippo Lococo, MD, Alfredo Cesario, MD, Stefano Margaritora,

Prognostic Significance of Tumor Size in Patients with Stage III Non–Small-Cell Lung Cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey.

Presentation transcript:

Malignant Solitary Fibrous Tumors of the Pleura: Retrospective Review of a Multicenter Series Filippo Lococo, MD, Alfredo Cesario, MD, Giuseppe Cardillo, PhD, Pierluigi Filosso, MD, Domenico Galetta, MD, Luigi Carbone, MD, Alberto Oliaro, MD, Lorenzo Spaggiari, PhD, Giacomo Cusumano, PhD, Stefano Margaritora, MD, Paolo Graziano, PhD, Pierluigi Granone, PhD Journal of Thoracic Oncology Volume 7, Issue 11, Pages 1698-1706 (November 2012) DOI: 10.1097/JTO.0b013e3182653d64 Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 Giant malignant solitary fibrous tumor of the pleura: Preoperative evaluation with (A) computed tomography scan; (B) surgical findings, and (C) pathological macroscopic features (dimension: 320 × 250 × 170 mm; weight: 2130 g). Journal of Thoracic Oncology 2012 7, 1698-1706DOI: (10.1097/JTO.0b013e3182653d64) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 Microscopical pathological findings (A) (hematoxylin and eosin × 100) of malignant solitary fibrous tumor; immunohistochemical positivity staining for (B) CD34 and (C) bcl-2. Journal of Thoracic Oncology 2012 7, 1698-1706DOI: (10.1097/JTO.0b013e3182653d64) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 3 Overall (A) LTS and (B) DFS in the entire cohort of patients. LTS, long-term survival; DFS, disease-free survival. Journal of Thoracic Oncology 2012 7, 1698-1706DOI: (10.1097/JTO.0b013e3182653d64) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 4 Prognostic factors affecting (A and B) LTS and (C and D) DFS. LTS, long-term survival; DFS, disease-free survival. Journal of Thoracic Oncology 2012 7, 1698-1706DOI: (10.1097/JTO.0b013e3182653d64) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions